PROSUS NV (PRX.AS) Stock Fundamental Analysis

Europe • Euronext Amsterdam • AMS:PRX • NL0013654783

45.89 EUR
-0.11 (-0.24%)
Last: Feb 9, 2026, 05:35 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PRX. PRX was compared to 13 industry peers in the Broadline Retail industry. PRX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PRX is growing strongly while it is still valued neutral. This is a good combination! These ratings could make PRX a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year PRX was profitable.
  • In the past year PRX had a positive cash flow from operations.
  • PRX had positive earnings in each of the past 5 years.
  • In multiple years PRX reported negative operating cash flow during the last 5 years.
PRX.AS Yearly Net Income VS EBIT VS OCF VS FCFPRX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

  • PRX has a Return On Assets of 16.85%. This is amongst the best in the industry. PRX outperforms 92.31% of its industry peers.
  • PRX has a better Return On Equity (24.24%) than 69.23% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 0.27%, PRX is doing worse than 76.92% of the companies in the same industry.
Industry RankSector Rank
ROA 16.85%
ROE 24.24%
ROIC 0.27%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
PRX.AS Yearly ROA, ROE, ROICPRX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

  • PRX has a Profit Margin of 196.38%. This is amongst the best in the industry. PRX outperforms 92.31% of its industry peers.
  • PRX's Profit Margin has improved in the last couple of years.
  • The Operating Margin of PRX (3.87%) is worse than 76.92% of its industry peers.
  • PRX has a worse Gross Margin (45.21%) than 61.54% of its industry peers.
  • PRX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.87%
PM (TTM) 196.38%
GM 45.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
PRX.AS Yearly Profit, Operating, Gross MarginsPRX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRX is destroying value.
  • Compared to 1 year ago, PRX has less shares outstanding
  • PRX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, PRX has an improved debt to assets ratio.
PRX.AS Yearly Shares OutstandingPRX.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PRX.AS Yearly Total Debt VS Total AssetsPRX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • PRX has an Altman-Z score of 4.39. This indicates that PRX is financially healthy and has little risk of bankruptcy at the moment.
  • PRX has a Altman-Z score of 4.39. This is amongst the best in the industry. PRX outperforms 84.62% of its industry peers.
  • PRX has a debt to FCF ratio of 9.30. This is a negative value and a sign of low solvency as PRX would need 9.30 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 9.30, PRX is in line with its industry, outperforming 46.15% of the companies in the same industry.
  • A Debt/Equity ratio of 0.30 indicates that PRX is not too dependend on debt financing.
  • PRX has a better Debt to Equity ratio (0.30) than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Altman-Z 4.39
ROIC/WACC0.04
WACC7.48%
PRX.AS Yearly LT Debt VS Equity VS FCFPRX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B 50B

2.3 Liquidity

  • PRX has a Current Ratio of 3.66. This indicates that PRX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.66, PRX belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
  • A Quick Ratio of 3.62 indicates that PRX has no problem at all paying its short term obligations.
  • The Quick ratio of PRX (3.62) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.66
Quick Ratio 3.62
PRX.AS Yearly Current Assets VS Current LiabilitesPRX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

7

3. Growth

3.1 Past

  • PRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.14%, which is quite impressive.
  • Measured over the past years, PRX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.24% on average per year.
  • Looking at the last year, PRX shows a quite strong growth in Revenue. The Revenue has grown by 16.28% in the last year.
  • The Revenue has been growing by 13.13% on average over the past years. This is quite good.
EPS 1Y (TTM)87.14%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%35.96%
Revenue 1Y (TTM)16.28%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%22.27%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.79% on average over the next years. This is quite good.
  • PRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.04% yearly.
EPS Next Y23.12%
EPS Next 2Y21.48%
EPS Next 3Y20.29%
EPS Next 5Y11.79%
Revenue Next Year31.84%
Revenue Next 2Y31.18%
Revenue Next 3Y25.44%
Revenue Next 5Y16.04%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRX.AS Yearly Revenue VS EstimatesPRX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
PRX.AS Yearly EPS VS EstimatesPRX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.27, the valuation of PRX can be described as very reasonable.
  • Based on the Price/Earnings ratio, PRX is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of PRX to the average of the S&P500 Index (27.93), we can say PRX is valued rather cheaply.
  • PRX is valuated reasonably with a Price/Forward Earnings ratio of 11.16.
  • PRX's Price/Forward Earnings ratio is rather cheap when compared to the industry. PRX is cheaper than 92.31% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.77, PRX is valued rather cheaply.
Industry RankSector Rank
PE 9.27
Fwd PE 11.16
PRX.AS Price Earnings VS Forward Price EarningsPRX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRX indicates a rather expensive valuation: PRX more expensive than 92.31% of the companies listed in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as PRX.
Industry RankSector Rank
P/FCF 67.38
EV/EBITDA 341.67
PRX.AS Per share dataPRX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • PRX's earnings are expected to grow with 20.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.4
PEG (5Y)0.54
EPS Next 2Y21.48%
EPS Next 3Y20.29%

3

5. Dividend

5.1 Amount

  • PRX has a yearly dividend return of 0.44%, which is pretty low.
  • In the last 3 months the price of PRX has falen by -21.97%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • PRX's Dividend Yield is a higher than the industry average which is at 0.56.
  • With a Dividend Yield of 0.44, PRX pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.44%

5.2 History

  • The dividend of PRX decreases each year by -19.73%.
Dividend Growth(5Y)-19.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • PRX pays out 2.00% of its income as dividend. This is a sustainable payout ratio.
DP2%
EPS Next 2Y21.48%
EPS Next 3Y20.29%
PRX.AS Yearly Income VS Free CF VS DividendPRX.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
PRX.AS Dividend Payout.PRX.AS Dividend Payout, showing the Payout Ratio.PRX.AS Dividend Payout.PayoutRetained Earnings

PROSUS NV

AMS:PRX (2/9/2026, 5:35:15 PM)

45.89

-0.11 (-0.24%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-24
Earnings (Next)N/A
Inst Owners65.13%
Inst Owner ChangeN/A
Ins Owners0.88%
Ins Owner ChangeN/A
Market Cap109.17B
Revenue(TTM)6.83B
Net Income(TTM)13.41B
Analysts80
Price Target67.62 (47.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.44%
Yearly Dividend0.04
Dividend Growth(5Y)-19.73%
DP2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.02%
PT rev (3m)5.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.87%
EPS NY rev (3m)-0.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.24%
Valuation
Industry RankSector Rank
PE 9.27
Fwd PE 11.16
P/S 18.85
P/FCF 67.38
P/OCF 63.93
P/B 2.33
P/tB 2.5
EV/EBITDA 341.67
EPS(TTM)4.95
EY10.79%
EPS(NY)4.11
Fwd EY8.96%
FCF(TTM)0.68
FCFY1.48%
OCF(TTM)0.72
OCFY1.56%
SpS2.43
BVpS19.72
TBVpS18.35
PEG (NY)0.4
PEG (5Y)0.54
Graham Number46.87
Profitability
Industry RankSector Rank
ROA 16.85%
ROE 24.24%
ROCE 0.36%
ROIC 0.27%
ROICexc 0.29%
ROICexgc 0.3%
OM 3.87%
PM (TTM) 196.38%
GM 45.21%
FCFM 27.98%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
F-Score7
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Debt/EBITDA 40.19
Cap/Depr 70.55%
Cap/Sales 1.51%
Interest Coverage 0.46
Cash Conversion 491.22%
Profit Quality 14.25%
Current Ratio 3.66
Quick Ratio 3.62
Altman-Z 4.39
F-Score7
WACC7.48%
ROIC/WACC0.04
Cap/Depr(3y)83.48%
Cap/Depr(5y)79.69%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.14%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%35.96%
EPS Next Y23.12%
EPS Next 2Y21.48%
EPS Next 3Y20.29%
EPS Next 5Y11.79%
Revenue 1Y (TTM)16.28%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%22.27%
Revenue Next Year31.84%
Revenue Next 2Y31.18%
Revenue Next 3Y25.44%
Revenue Next 5Y16.04%
EBIT growth 1Y576.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year358.66%
EBIT Next 3Y107.43%
EBIT Next 5YN/A
FCF growth 1Y289.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y217.17%
OCF growth 3YN/A
OCF growth 5YN/A

PROSUS NV / PRX.AS FAQ

Can you provide the ChartMill fundamental rating for PROSUS NV?

ChartMill assigns a fundamental rating of 6 / 10 to PRX.AS.


Can you provide the valuation status for PROSUS NV?

ChartMill assigns a valuation rating of 6 / 10 to PROSUS NV (PRX.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for PROSUS NV?

PROSUS NV (PRX.AS) has a profitability rating of 5 / 10.


What is the earnings growth outlook for PROSUS NV?

The Earnings per Share (EPS) of PROSUS NV (PRX.AS) is expected to grow by 23.12% in the next year.


How sustainable is the dividend of PROSUS NV (PRX.AS) stock?

The dividend rating of PROSUS NV (PRX.AS) is 3 / 10 and the dividend payout ratio is 2%.